The expression of Bax and Caspase-3 was upregulated while Bcl-2 expression was downregulated in BPD mice treated with miR-29a antagomir when compared to the mice exposed to RA following miR-29a antagomir treatment (p < 0.05). This evidence concerns the gene BCL2 and bronchopulmonary dysplasia.